Psyence Biomedical Ltd. (PBMWW) stock

PBMWWNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBM

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 22, 2026Score 0/30

$0.01−0.00 (-2.50%)

Close on Oct 30, 2026Market cap –P/E –Yield –

Psyence Biomedical gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Psyence Biomedical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.